A. Trifilieff

709 total citations
15 papers, 590 citations indexed

About

A. Trifilieff is a scholar working on Molecular Biology, Physiology and Genetics. According to data from OpenAlex, A. Trifilieff has authored 15 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Physiology and 4 papers in Genetics. Recurrent topics in A. Trifilieff's work include Asthma and respiratory diseases (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers) and Chemical Synthesis and Analysis (3 papers). A. Trifilieff is often cited by papers focused on Asthma and respiratory diseases (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers) and Chemical Synthesis and Analysis (3 papers). A. Trifilieff collaborates with scholars based in Switzerland, France and United Kingdom. A. Trifilieff's co-authors include Anthony J. Coyle, Claude Bertrand, S Tsuyuki, Robin A. Fairhurst, Mathiéu Molimard, Gary P. Anderson, Emmanuel Naline, Charles Advenier, M. Wesp and François Erard and has published in prestigious journals such as Journal of Clinical Investigation, American Journal of Respiratory and Critical Care Medicine and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

A. Trifilieff

15 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Trifilieff Switzerland 12 301 196 188 176 76 15 590
Giorgio Giannattasio Italy 12 133 0.4× 211 1.1× 74 0.4× 254 1.4× 43 0.6× 22 591
Michele Columbo United States 16 361 1.2× 216 1.1× 114 0.6× 526 3.0× 101 1.3× 41 957
Shoko Iwaki United States 15 209 0.7× 168 0.9× 74 0.4× 486 2.8× 48 0.6× 18 784
Paul M. Seldon United Kingdom 9 180 0.6× 153 0.8× 86 0.5× 151 0.9× 9 0.1× 9 455
Sung Gil Ha United States 16 189 0.6× 353 1.8× 71 0.4× 259 1.5× 8 0.1× 21 670
Matthew T. Hardison United States 8 102 0.3× 122 0.6× 152 0.8× 113 0.6× 10 0.1× 9 467
Yves T. Falanga United States 11 166 0.6× 247 1.3× 31 0.2× 315 1.8× 23 0.3× 15 570
Travis H. Wyman United States 7 97 0.3× 156 0.8× 47 0.3× 127 0.7× 32 0.4× 8 573
Melker Göransson Sweden 12 173 0.6× 410 2.1× 144 0.8× 70 0.4× 12 0.2× 14 673
Christine R. Keenan Australia 16 148 0.5× 289 1.5× 125 0.7× 185 1.1× 13 0.2× 28 634

Countries citing papers authored by A. Trifilieff

Since Specialization
Citations

This map shows the geographic impact of A. Trifilieff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Trifilieff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Trifilieff more than expected).

Fields of papers citing papers by A. Trifilieff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Trifilieff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Trifilieff. The network helps show where A. Trifilieff may publish in the future.

Co-authorship network of co-authors of A. Trifilieff

This figure shows the co-authorship network connecting the top 25 collaborators of A. Trifilieff. A scholar is included among the top collaborators of A. Trifilieff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Trifilieff. A. Trifilieff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Rosethorne, Elizabeth M., David A. Sykes, John D. Wright, et al.. (2016). Long Receptor Residence Time of C26 Contributes to Super Agonist Activity at the Human β2 Adrenoceptor. Molecular Pharmacology. 89(4). 467–475. 12 indexed citations
2.
Yelensky, Roman, Steve Lewitzky, Elizabeth C. LeRoy, et al.. (2011). A pharmacogenetic study of ADRB2 polymorphisms and indacaterol response in COPD patients. The Pharmacogenomics Journal. 12(6). 484–488. 11 indexed citations
3.
Trifilieff, A., et al.. (2009). Role of sphingosine-1-phosphate (S1P) and the S1P2 receptor in allergen-induced, mast cell-dependent contraction of rat lung parenchymal strips. Naunyn-Schmiedeberg s Archives of Pharmacology. 380(4). 303–309. 11 indexed citations
4.
Cannet, Catherine, Stefan Zurbruegg, Catherine Gérard, et al.. (2009). Activation of the lung S1P1 receptor reduces allergen‐induced plasma leakage in mice. British Journal of Pharmacology. 158(5). 1295–1301. 19 indexed citations
5.
Wyss, Daniel F., Olivier Bonneau, & A. Trifilieff. (2007). Synergistic effect of formoterol and mometasone in a mouse model of allergic lung inflammation. British Journal of Pharmacology. 152(1). 83–90. 15 indexed citations
6.
Naline, Emmanuel, A. Trifilieff, Robin A. Fairhurst, Charles Advenier, & Mathiéu Molimard. (2006). Effect of indacaterol, a novel long-acting β2-agonist, on isolated human bronchi. European Respiratory Journal. 29(3). 575–581. 81 indexed citations
7.
Wymann, Matthias P., Katja Björklöf, Ronan Calvez, et al.. (2003). Phosphoinositide 3-kinase γ: a key modulator in inflammation and allergy. Biochemical Society Transactions. 31(1). 275–280. 112 indexed citations
8.
Trifilieff, A., et al.. (2001). IL‐5 deficiency abolishes aspects of airway remodelling in a murine model of lung inflammation. Clinical & Experimental Allergy. 31(6). 934–942. 48 indexed citations
9.
Trifilieff, A., et al.. (1997). Endothelin Receptor Antagonists Inhibit Antigen-Induced Lung Inflammation in Mice. American Journal of Respiratory and Critical Care Medicine. 155(6). 1890–1894. 44 indexed citations
10.
Amrani, Yassine, et al.. (1995). Involvement of B2 receptors in the bradykinin‐induced relaxation of guinea‐pig isolated trachea. British Journal of Pharmacology. 114(1). 103–108. 14 indexed citations
11.
Tsuyuki, S, Claude Bertrand, François Erard, et al.. (1995). Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways.. Journal of Clinical Investigation. 96(6). 2924–2931. 126 indexed citations
12.
Haddad, E B, et al.. (1993). Heterogeneity of Guinea-Pig Lung Muscarinic Receptors Revealed by [3H]4-DAMP-binding. Pulmonary Pharmacology. 6(2). 119–127. 9 indexed citations
13.
Trifilieff, A., et al.. (1993). Kinins and respiratory tract diseases. European Respiratory Journal. 6(4). 576–587. 61 indexed citations
14.
Trifilieff, A., et al.. (1992). Effect of Hoe 140, a new B2 noncompetitive antagonist, on guinea pig tracheal bradykinin receptors.. Journal of Pharmacology and Experimental Therapeutics. 263(3). 1377–1382. 25 indexed citations
15.
Trifilieff, A., et al.. (1991). [Bradykinin and asthma].. PubMed. 8(4). 339–50. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026